← Back to Clinical Trials
Recruiting NCT07242742

NCT07242742 Effectiveness of Pulpotomy vs. Root Canal Treatment in Extremely Deep Caries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07242742
Status Recruiting
Phase
Sponsor National University Hospital, Singapore
Condition Extremely Deep Caries
Study Type INTERVENTIONAL
Enrollment 93 participants
Start Date 2025-07-16
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Full Pulpotomyroot canal treatment and intracanal medicament

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 93 participants in total. It began in 2025-07-16 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Recent clinical trials comparing pulpotomy versus root canal treatment (RCT) have shown promising outcomes; however, the current evidence lacks generalisability to general practitioners. It remains to be elucidated whether these favourable results can be replicated in a primary care setting. This study aims to address that gap by involving senior dental students undergoing supervised university education and training, with the potential to inform future best practice guidelines and promote the adoption of vital pulp therapy (VPT) as a predictable treatment alternative in the general dental population. The clinical procedure involves complete caries-free excavation carried out under rubber dam isolation. After confirming vital pulp status-demonstrated by bleeding upon entry, participants will be randomised to receive one of two treatments: RCT or full pulpotomy. Outcomes will include clinical and radiographic success or failure of the intervention at 12 months. Additionally, patient-reported outcomes will be collected, specifically pain experienced and the use of analgesia during the immediate post-operative period (days 3 and 7).

Eligibility Criteria

Inclusion Criteria: * Aged 12 years or older * Mature maxillary or mandibular permanent tooth with extremely deep restorations/caries penetrating the entire thickness of dentine on the radiograph without a radiopaque zone separating the lesion from the pulp (Bjorndal et al., 2019) * Tooth may or may not be symptomatic at the time of recruitment but must be responsive to cold and EPT sensibility testing * Tooth is restorable and can be adequately isolated during treatment * One tooth per patient Exclusion Criteria: * Teeth with difficult access and unpredictable isolation using a rubber dam * Teeth aberrant root canal morphology, extreme root curvatures (\>30 degrees), calcified canals/sclerosed pulp * Teeth indicated for elective root canal treatment for restorative purposes * Teeth with apical periodontitis * Presence of apical radiolucency * Any evidence of purulence or excessive bleeding that cannot be controlled with a cotton pellet with 1.25% hypochlorite for 10 minutes * History of trauma to the tooth * Teeth with active periodontal disease (pocket depth \>5mm) * Patients with complex medical histories that may affect their caries experience and healing ability (immunocompromised, radiotherapy etc.) * Patients who are pregnant or breast-feeding * Patients who are unable to consent

Contact & Investigator

Central Contact

Victoria Yu

✉ denyshv@nus.edu.sg

📞 (65) 9004 1044

Frequently Asked Questions

Who can join the NCT07242742 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, studying Extremely Deep Caries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07242742 currently recruiting?

Yes, NCT07242742 is actively recruiting participants. Contact the research team at denyshv@nus.edu.sg for enrollment information.

Where is the NCT07242742 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT07242742 clinical trial?

NCT07242742 is sponsored by National University Hospital, Singapore. The trial plans to enroll 93 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology